Vanberra Signal

SimplicityBio

Curated by Signal

In-silico solutions for bioinformatics

Overview

SimplicityBio is a biomarker discovery company which provides in-silico solutions for bioinformatics. Services include in-silico biomarker discovery and biomarker ranking, signature creation (biomarkers + classification algorithm) and improvement of an existent signature (sensitivity, specificity and robustness). It identifies biomarkers which can be used for diagnostics, patient stratification, follow-up or treatment response of certain diseases. As molecular diagnostic tests must reach certain sensitivity and specificity thresholds set by regulatory bodies in order to reach the market (e.g. CE IVD mark, FDA approval), its technology can be used for signature creation and improvement.

Key facts

Founded
2013

More on Vanberra Signal

Members only

Competitors & similar companies

More Life Sciences Technology companies
  • Provider of an AI-based sleep monitoring device for patients and physicians

    Life Sciences TechnologyZurich, Switzerland
  • Developer of AI-based stethoscope

    Life Sciences TechnologySwitzerland
  • Developing anti-cancer small molecules targeting novel drug resistance pathways

    Life Sciences TechnologyZurich, Switzerland

About SimplicityBio

What does SimplicityBio do?

SimplicityBio is a biomarker discovery company which provides in-silico solutions for bioinformatics.

Where is SimplicityBio headquartered?

SimplicityBio is headquartered in Monthey, Switzerland.

When was SimplicityBio founded?

SimplicityBio was founded in 2013.

Which sector is SimplicityBio in?

SimplicityBio operates in Life Sciences Technology.

Who are SimplicityBio's competitors?

Companies similar to SimplicityBio include Sleepiz, Pneumoscope, and TOLREMO therapeutics.